This site uses cookies to store information on your computer. Some cookies on this site are essential and the site won't work as expected without them. To learn more about cookies and their benefits, please view cookies policy. By closing this message or navigating within the website, you consent to our use of cookies on this device in accordance with our cookie policy, unless you have disabled them.
By clicking Continue, you confirm that you are a healthcare professional In the UK.
▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.
If you get any side effects, talk to your healthcare professional. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Sanofi and Regeneron are collaborating in a global development programme and commercialisation for Dupixent.
NICE guidance. Available at: https://www.nice.org.uk/guidance/indevelopment/gid-ta10276/documents/final-appraisal-determination-document. Date accessed: November 2021.
